E-viri
Recenzirano
-
Ioannidis, John P. A
JAMA : the journal of the American Medical Association, 02/2014, Letnik: 311, Številka: 5Journal Article
The American College of Cardiology/American Heart Association (ACC/AHA) guidelines on assessment of cardiovascular risk and on treatment of blood cholesterol, which included recommendations for primary prevention with statins, came under intense criticism immediately with their release. Main concerns focused on flawed methods (problems with the risk calculation), ethics (conflicts of interest), and inferences (too many people offered treatment). The ACC and the AHA are among the most experienced organizations in medicine that develop guidelines. Their processes are meticulous, including transparent reporting of conflicts. Here, Ioannidis discusses the potential implications of the new cardiovascular guidelines.
